Abstract: Marine oil compositions which contain EPA and DHA as free acids or hexyl esters are esterified with ethanol in the presence of a lipase catalyst under essentially organic solvent-free conditions and separated by distillation.
Type:
Grant
Filed:
October 31, 2003
Date of Patent:
February 17, 2009
Assignee:
Pronova Biocare AS
Inventors:
Gudmundur G. Haraldsson, Arnar Halldorsson, Olav Thorstad
Abstract: A method and composition for blood lipid therapy by administering to the subject an effective amount of a dyslipidemic agent and omega-3 fatty acids. The method utilizes a single administration or a unit dosage of a combination of dyslipidemic agent and omega-3 fatty acids for the treatment of patients with hypertriglyceridemia, hypercholesterolemia, mixed dyslipidemia, coronary heart disease (CHD), vascular disease, artherosclerotic disease and related conditions, and the prevention or reduction of cardiovascular and vascular events.
Type:
Application
Filed:
September 15, 2008
Publication date:
January 8, 2009
Applicants:
RELIANT PHARMACEUTICALS, INC., PRONOVA BIOCARE AS
Inventors:
Roelof M. L. RONGEN, George BOBOTAS, Egil BODD, Hogne VIK
Abstract: Marine oil compositions which contain EPA and DHA as free acids or hexyl esters are esterified with ethanol in the presence of a lipase catalyst under essentially organic solvent-free conditions and separated by distillation.
Type:
Application
Filed:
October 31, 2003
Publication date:
July 6, 2006
Applicant:
Pronova Biocare AS
Inventors:
Gudmundur Haraldsson, Arnar Halldorsson, Olav Thostad
Abstract: A liquid nutritional and/or refreshing preparation is described to which an emulsion is added containing oils with polyunsaturated fatty acids and remedial substances in a water-based drink, in such a manner that the drink does not turn rancid within the storage time of the water-based phase, a method for its production and its application.
Abstract: A liquid nutritional and/or refreshing preparation is described to which an emulsion is added containing oils with polyunsaturated fatty acids and remedial substances in a water-based drink, in such a manner that the drink does not turn rancid within the storage time of the water-based phase, a method for its production and its application.
Abstract: A statistically significant benefit is observed in the treatment of IgA nephropathy by administration of Omega-3 fatty acids in a dosing regimen dependent on the size of the patient.
Abstract: The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amide, a free fatty acid and a hydro-carbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant pre-sent in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics.